Exploring Dolichos lablab compounds as potential inhibitors for fusion (F) protein of human metapneumovirus (HMPV): A systematic computational approach
PLOS One · 2025
DOI: 10.1371/journal.pone.0332170 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Md Mainuddin Hossain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh. Hauptthemen laut MEDLINE: Metapneumovirus, Viral Fusion Proteins, Antiviral Agents, Viral Fusion Protein Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
One of the most crucial respiratory pathogens in the world, namely human metapneumovirus (HMPV), causes acute upper and lower respiratory tract infection. The HMPV Fusion (F) protein is a vital element for viral entry and is the sole target of neutralizing antibodies, making it a prime target for drug and vaccine development. Targeting the Fusion (F) protein of HMPV for inhibition has emerged as a potential therapeutic strategy, particularly in respiratory infection treatment. We aimed to identify potential inhibitors against HMPV F protein by molecular docking and molecular dynamics study. Through molecular docking, we were able to identify 16 lead compounds derived from Dolichos lablab (DL) . These compounds exhibited robust binding affinities with the HMPV F protein, with better docking scores compared to the ribavirin inhibitor as a control with a −6.7 kcal/mol docking score. Among these top-ranked compounds, Brassinolide (CID_115196), Quercetin (CID_5280343), and 2’-Hydroxygenistein (CID_5282074) demonstrated favorable molecular, pharmacokinetics, and drug-like properties, promising biological activities, and acceptable toxicity profiles. Furthermore, Brassinolide, Quercetin, and 2’-Hydroxygenistein were found to be promising drug inhibitors with the greatest binding stability against the HMPV F protein compared to the ribavirin inhibitor, which is validated by the highest protein-ligand interactions and lowest Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), and Radius of Gyration (Rg) values using 100 ns molecular dynamic simulation. Our study provides valuable insights into the therapeutic potential of DL compounds as potential or hypothetical inhibitors for HMPV F protein having three promising candidates- Brassinolide, Quercetin, and 2’-Hydroxygenistein. These results warrant further validation through detailed in vitro and in vivo investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology and Genetic Engineering, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Ministry of Public Administration, Dhaka, Bangladesh.
- Department of Computer Science and Engineering, Comilla University, Comilla, Bangladesh.
- Department of Chemistry, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
- Department of Biotechnology and Genetic Engineering, Noakhali Science and Technology University, Noakhali, Bangladesh.
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh.
ORCID-Profile: Md Mainuddin Hossain, Md Mahbub Morshed
Zitieren
APA
Hossain, M. M., Apu, M. J. H., Aziz, M. F. B. A., Tanjil, M. T. R., Das, L. C., Kar, A., Evamoni, F. Z., & Morshed, M. M. (2025). Exploring Dolichos lablab compounds as potential inhibitors for fusion (F) protein of human metapneumovirus (HMPV): A systematic computational approach. PLOS One. https://doi.org/10.1371/journal.pone.0332170
Vancouver
Hossain MM, Apu MJH, Aziz MFBA, Tanjil MTR, Das LC, Kar A, et al. Exploring Dolichos lablab compounds as potential inhibitors for fusion (F) protein of human metapneumovirus (HMPV): A systematic computational approach. PLOS One. 2025. doi:10.1371/journal.pone.0332170
BibTeX
@article{Hossain2025,
author = {Hossain, Md Mainuddin and Apu, Md Jahid Hasan and Aziz, Md Faisal Bin Abdul and Tanjil, Md Tanzimur Rahman and Das, Liton Chandra and Kar, Antora and Evamoni, Fatematuz Zuhura and Morshed, Md Mahbub},
title = {Exploring Dolichos lablab compounds as potential inhibitors for fusion (F) protein of human metapneumovirus (HMPV): A systematic computational approach},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0332170}
}
EUVIMED